1. Accelerating bleaching in vitiligo: balancing benefits versus risks. Issue 12 (December 2014) Authors: Seneschal, Julien; Boniface, Katia; Ezzedine, Khaled; Taieb, Alain Journal: Experimental dermatology Issue: Volume 23:Issue 12(2014:Dec.) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An update on Vitiligo pathogenesis. (15th December 2020) Authors: Seneschal, Julien; Boniface, Katia; D'Arino, Andrea; Picardo, Mauro Journal: Pigment cell & melanoma research Issue: Volume 34:Number 2(2021) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of Vitiligo Area Scoring Index (VASI), Facial‐VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo. (10th May 2022) Authors: Merhi, Ribal; Canu, Dorine; Barnetche, Thomas; Duchez, Elodie; Gey, Aurélia; Andreu, Nicolas; Taieb, Alain; Boniface, Katia; Seneschal, Julien Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of Vitiligo Area Scoring Index (VASI), Facial‐VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo. (1st September 2022) Authors: Merhi, Ribal; Canu, Dorine; Barnetche, Thomas; Duchez, Elodie; Gey, Aurélia; Andreu, Nicolas; Taieb, Alain; Boniface, Katia; Seneschal, Julien Journal: British journal of dermatology Issue: Volume 187:Number 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events. (November 2021) Authors: Kostine, Marie; Mauric, Eleonora; Tison, Alice; Barnetche, Thomas; Barre, Aurélien; Nikolski, Macha; Rouxel, Léa; Dutriaux, Caroline; Dousset, Léa; Prey, Sorilla; Beylot-Barry, Marie; Seneschal, Julien; Veillon, Rémi; Vergnenegre, Charlotte; Daste, Amaury; Domblides, Charlotte; Sionneau, Baptiste... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comment: the mystery of melanocyte demise in vitiligo. Issue 4 (April 2015) Authors: Boniface, Katia; Rezvani, Hamid R.; Seneschal, Julien; Taïeb, Alain Journal: Experimental dermatology Issue: Volume 24:Issue 4(2015:Apr.) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and validation of the K‐VSCOR for scoring Koebner's phenomenon in vitiligo/non‐segmental vitiligo. (30th January 2013) Authors: Diallo, Abou; Boniface, Katia; Jouary, Thomas; Seneschal, Julien; Morice‐Picard, Fanny; Prey, Sorilla; Cario‐André, Muriel; Mazereeuw‐Hautier, Juliette; Taieb, Alain; Ezzedine, Khaled Journal: Pigment cell & melanoma research Issue: Volume 26:Number 3(2013:May) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Disseminated cutaneous granulomatosis as a manifestation of myelodysplastic syndrome. (28th November 2020) Authors: Luherne, Camille; Menguy, Sarah; Seneschal, Julien; Pham‐Ledard, Anne; Beylot‐Barry, Marie Journal: International journal of dermatology Issue: Volume 60:Number 5(2021) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of ruxolitinib cream on achievement of VASI50 by body region: Week 52 pooled analysis of the TRuE-V phase 3 studies. (18th January 2023) Authors: Passeron, Thierry; Harris, John E; Pandya, Amit G; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Butler, Kathleen; Ezzedine, Khaled; Rosmarin, David Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Week 52 pooled subgroup analysis from two randomized phase 3 studies. (18th January 2023) Authors: Seneschal, Julien; Wolkerstorfer, Albert; Desai, Seemal R; Grimes, Pearl; Ezzedine, Khaled; Kornacki, Deanna; Wei, Shaoceng; Butler, Kathleen; Rosmarin, David Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗